NeoImmuneTech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	46,270	81,170	111,226	200,207	394,816	1,018,357
Market Cap Growth	-57.80%	-27.02%	-44.44%	-49.29%	-61.23%	-
Enterprise Value	-4,060	21,246	74,945	122,886	259,580	856,774
Last Close Price	468.00	821.00	934.40	1681.92	3318.17	8596.50
PS Ratio	487.96	856.01	652.79	-	-	-
PB Ratio	0.78	1.37	2.67	2.68	3.30	6.29
P/TBV Ratio	1.00	1.75	3.16	2.92	3.49	6.55
EV/Sales Ratio	-	224.06	439.86	-	-	-
Debt / Equity Ratio	0.18	0.18	0.26	0.05	0.04	0.04
Net Debt / Equity Ratio	-0.85	-0.85	-0.57	-0.87	-0.94	-0.92
Net Debt / EBITDA Ratio	2.20	2.20	0.64	1.24	2.03	2.97
Net Debt / FCF Ratio	2.00	2.00	0.59	1.29	2.50	4.06
Asset Turnover	0.00	0.00	0.00	-	-	-
Quick Ratio	2.94	2.94	1.67	5.36	7.14	7.57
Current Ratio	3.08	3.08	1.89	5.61	7.20	8.17
Return on Equity (ROE)	-63.04%	-63.04%	-70.17%	-54.90%	-42.88%	-42.62%
Return on Assets (ROA)	-21.48%	-21.48%	-32.84%	-30.30%	-22.25%	-22.95%
Return on Capital Employed (ROCE)	-41.30%	-41.30%	-91.80%	-71.90%	-47.10%	-31.20%
Earnings Yield	-68.72%	-39.17%	-36.76%	-26.67%	-15.30%	-5.15%
FCF Yield	-54.32%	-30.96%	-36.51%	-25.25%	-11.37%	-3.59%
Buyback Yield / Dilution	-19.34%	-19.34%	0.24%	-0.08%	-3.68%	-15.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.